You are here

The Murdoch Children's Research Institute blog Featuring stories, opinons and news from our research team, patients and staff.

The Longitudinal Study of Australian Children, already a rich source of evidence on the health and wellbeing of our children, is now gathering new evidence on a “public health emergency in slow motion”: the growing burden of non-communicable diseases, writes Professor Melissa Wake.
Freya Harewood of the Murdoch Children's Infectious Diseases and Microbiology Group explains how one cheap and available vaccine could have significant impact on reducing the burden of illness, and potentially even allergies in children. The vaccine in question is likely known to many Australian parents - the Bacillus Calmette-Guérin (BCG) vaccine – if it is unfamiliar to you understanding the potential added benefits to this vaccine could be paramount to your child’s health. Freya shares the focus of her research:
This September 17, our family and friends will celebrate the inaugural Kleefstra Syndrome Awareness Day. Our little girl Olivia is one of a just a few hundred people in the world who have been diagnosed with rare genetic fault which results in severe developmental delays, intellectual disabilities and physical abnormalities. To us, she is perfect.